branchenspezifische Dividenden Charles River Laboratories International, Inc. Berne S.E.
Aktien
939391
US1598641074
RV6
Biotechnologie
|
Schlusskurs
Berne S.E.
28.09.2026
|
Perf. 5 T | Veränd. 1. Jan. | ||
| 243.60 CHF | +0.92% |
|
+6.87% | - |
| 28.09. | Charles River Laboratories International, Inc. : Jefferies & Co. gibt eine Kauf-Bewertung ab | ZM |
| 25.09. | Segment von Charles River Laboratories bietet größtes Margenpotenzial, sagt RBC | MT |
Hauptkonkurrenten
| Dividendenrendite (Y) | Dividendenrendite (Y+1) | KGV (Y) | Price to Book (Y) | EV / Umsatz (Y) | Marktkap. / EBITDA (Y) | Marktkap. / EBIT (Y) | Marktkap.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 0.95% | 1.1% | 34.14x | 4.56x | 6.12x | 18.32x | 25.63x | 49.06 Mrd. | ||
| -.--% | -.--% | 34.9x | 6.37x | 3.36x | 14.48x | 21.88x | 44.6 Mrd. | ||
| -.--% | -.--% | -20.74x | 21.86x | 225.54x | -22.4x | -21.23x | 43.24 Mrd. | ||
| -.--% | -.--% | 48.07x | 8.14x | 5.56x | 30.53x | 35.12x | 41.73 Mrd. | ||
| 0.42% | 0.44% | 26.98x | 2.19x | 7.78x | 20.03x | 23.46x | 29.93 Mrd. | ||
| -.--% | -.--% | 35.03x | 25.13x | 5.75x | 26.11x | 27.32x | 17.19 Mrd. | ||
| -.--% | -.--% | -61.09x | 30.62x | 9.99x | 243.97x | -1855.23x | 15.35 Mrd. | ||
| 1.02% | 1.15% | 26.24x | 2.91x | 2.25x | 9.73x | 15.09x | 15.54 Mrd. | ||
| -.--% | -.--% | 78.28x | 4.67x | 4.13x | 15.8x | 19.68x | 14.06 Mrd. | ||
| -.--% | -.--% | 29.8x | 1.41x | 1.95x | 11.98x | 13.65x | 13.55 Mrd. | ||
| -.--% | -.--% | -447.65x | 2.93x | 13.73x | 81.56x | 106.71x | 12.21 Mrd. | ||
| 0.44% | 0.44% | 52.48x | 4.58x | 8.71x | 24.72x | 29.48x | 11.37 Mrd. | ||
| 0.56% | 0.7% | 39.21x | 4.57x | 4.67x | 19.94x | 31.78x | 10.86 Mrd. | ||
| -.--% | -.--% | -28.92x | 8.41x | 76.27x | -19.13x | -18.59x | 9.31 Mrd. | ||
| -.--% | -.--% | 30.63x | - | 16x | 29.21x | 28.53x | 9.22 Mrd. | ||
| 0.3% | 0.41% | 23.47x | 2.48x | 4.67x | 12.53x | 15.98x | 9.31 Mrd. | ||
| -.--% | -.--% | -20.35x | 8.35x | 1700.15x | -21.76x | -22.16x | 8.31 Mrd. | ||
| -.--% | -.--% | -20.56x | 7.1x | 8468.61x | -16.73x | -16.47x | 7.98 Mrd. | ||
| Durchschnitt | 0.21% | 0.24% | -7.78x | 8.60x | 586.96x | 26.61x | -85.52x | 20.16 Mrd. | |
| Nach Marktkapitalisierung gewichteter Durchschnitt | 0.25% | 0.28% | 6.01x | 9.21x | 258.88x | 23.61x | -60.43x |
- Börse
- Aktien
- 939391 Aktie
- 939391 Aktie
- Sektor Charles River Laboratories International, Inc.
- branchenspezifische Dividenden
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
















